Investigation of Myocardial Protection Efficacy of Cardioplegia Solutions Used in Open Heart Surgery

CompletedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

December 8, 2022

Primary Completion Date

July 24, 2023

Study Completion Date

July 24, 2023

Conditions
Cardiovascular DiseasesMyocardial Reperfusion Injury
Interventions
PROCEDURE

Patients with coronary artery bypass surgery routine procedural administration of cardioplegia solutions

To investigate the effectiveness of myocardial protection methods, blood samples were collected from the coronary sinus before the aortic cross-clamping and at 4 minutes after aortic cross-clamping, through a coronary sinus cannula with a yellow-capped gel tube. The collected blood samples were kept in an upright position for 20 minutes to allow separation into serum fraction, then centrifuged at 3000 g for 10 minutes (Beckman Coulter, Microfuge 16, USA). The obtained serums were aliquoted into 250 μl portions in Eppendorf tubes, separately for each patient.

PROCEDURE

Patients who underwent heart valve surgery without coronary artery disease routine procedural administration of cardioplegia solutions

To investigate the effectiveness of myocardial protection methods, blood samples were collected from the coronary sinus before the aortic cross-clamping and at 4 minutes after aortic cross-clamping, through a coronary sinus cannula with a yellow-capped gel tube. The collected blood samples were kept in an upright position for 20 minutes to allow separation into serum fraction, then centrifuged at 3000 g for 10 minutes (Beckman Coulter, Microfuge 16, USA). The obtained serums were aliquoted into 250 μl portions in Eppendorf tubes, separately for each patient.

Trial Locations (1)

34668

SBÜ. Dr. Siyami Ersek Göğüs Kalp ve Damar Cerrahisi Eğitim ve Araştırma Hastanesi Erişkin Kalp ve Damar Cerrahisi Kliniği, Istanbul

All Listed Sponsors
collaborator

Istanbul University - Cerrahpasa

OTHER

lead

Tamer cebe

OTHER